𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of peroxisome proliferator-activated receptor γ activity suppresses pancreatic cancer cell motility

✍ Scribed by Atsushi Nakajima; Ayako Tomimoto; Koji Fujita; Michiko Sugiyama; Hirokazu Takahashi; Ikuko Ikeda; Kunihiro Hosono; Hiroki Endo; Kyoko Yoneda; Hiroshi Iida; Masahiko Inamori; Kensuke Kubota; Satoru Saito; Noriko Nakajima; Koichiro Wada; Yoji Nagashima; Hitoshi Nakagama

Book ID
108584286
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
611 KB
Volume
99
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary culture model of peroxisome prol
Primary culture model of peroxisome proliferator-activated receptor γ activity in prostate cancer cells
✍ Yue Xu; Sunita Iyengar; Richard L. Roberts; Scott B. Shappell; Donna M. Peehl 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

## Abstract BRL 49653 (rosiglitazone) is a thiazolidinedione anti‐diabetic drug that activates the nuclear receptor, peroxisome proliferator‐activated receptor gamma (PPARγ). Pilot clinical trials have shown evidence of therapeutic activity of PPARγ agonists against prostate cancer. To more effecti

Activation of peroxisome proliferator-ac
Activation of peroxisome proliferator-activated receptor-γ by troglitazone (TGZ) inhibits human lung cell growth
✍ Mingyue Li; Tak W. Lee; Tony S.K. Mok; Timothy D. Warner; Anthony P.C. Yim; Geor 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

## Abstract Peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) is a member of the nuclear hormone receptor superfamily of ligand‐activated transcription factors and a crucial regulator of cellular differentiation. PPAR‐γ ligands have been demonstrated to inhibit growth of several cancer cell